• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. ADVANCED PATELLA 29M 3 PEG IMPLANT; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. ADVANCED PATELLA 29M 3 PEG IMPLANT; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL Back to Search Results
Catalog Number 200-07-29
Medical Device Problem Code Loosening of Implant Not Related to Bone-Ingrowth (4002)
Health Effect - Clinical Codes Pain (1994); Synovitis (2094); Osteolysis (2377); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581); Joint effusion (4849)
Date of Event 07/22/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that approximately 46 months after a left knee replacement procedure, the patient underwent a revision procedure to address prosthesis wear.No further issues or complications were reported.No additional information is available.
 
Additional Manufacturer Narrative
D10: concomitants: optetrak femoral aug block & screw (208-05-04, (b)(6)).Optetrak logic fit tibial tray (02-012-45-4030, (b)(6)).Optetrak logic stem extension femoral and tibial (02-012-60-1440, (b)(6)).Optetrak tibial stem extension screw (204-70-00, (b)(6)).Optetrak logic femoral component (02-010-06-0240, (b)(6)).Optetrak femoral aug block & screw (208-05-04, (b)(6)).Optetrak logic stem extension femoral and tibial (02-012-60-1440, (b)(6)).Optetrak logic femoral augment & screw posterior, cemented (02-010-06-0541, (b)(6)).Optetrak logic femoral augment & screw posterior, cemented (02-010-06-0541, (b)(6)).Smith & nephew cement restrictor depuy smartset ghv gentamicin bone cement x 4 optetrak logic femoral component (02-010-06-0240, (b)(6)).Truliant tibial insert (02-022-35-4013, (b)(6)).The device was not returned for evaluation and no medical or other records containing treatment information or patient information have been received; therefore, the reported event cannot be confirmed, nor can the circumstances or potential causes or contributors to the alleged event be evaluated.Should additional, material information become available that permits more analysis or conclusions, a supplemental report will be filed accordingly.
 
Additional Manufacturer Narrative
This follow-up report is being submitted to relay additional and/or corrected information.Corrected fields: a4, b5, g3, h6 clinical codes, component code, type of investigation, investigation findings.
 
Event or Problem Description
It is documented via legal documentation approximately 46 months after a revision left knee replacement surgery, the patient underwent a second revision left knee replacement surgery.The patient experienced left anterior knee pain and recurrent effusions.A revision operative report was provided pre-operative work up for infection was noted to be negative.X-rays showed loosening of patellar component with osteolysis.Intraoperatively the tibial insert, upon removal, was noted to have signs of oxidative changes.The femoral and tibial components were noted to be well fixed.The patellar component was significantly loose.The surgeon observed and noted a very thin patella with concavity.It was elected to proceed with bone grafting and not resurfacing.There were no medical or surgical interventions reported.No additional information is available.
 
Additional Manufacturer Narrative
This follow-up report is being submitted to relay additional and/or corrected information.The following sections were updated/corrected: h6.Mdr section codes updated/corrected: b, c, g.The reason for the revision reported cannot be confirmed from the information provided but may be the result of patellar loosening or due to inclusion of the polyethylene in the packaging recall.Failure of the cement used to secure the patella implant to the patellar bone, may have lead to loosening at the cement-bone interface; however, this cannot be confirmed.Potential contributions of user and patient-related considerations to the event could not be assessed as the devices were not available for evaluation.If any further information is obtained that would change or alter any information provided, a supplemental report will be filed accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANCED PATELLA 29M 3 PEG IMPLANT
Common Device Name
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer (Section G)
EXACTECH INC
2320 nw 66th ct
gainesville FL 32653
Manufacturer Contact
geoff gannon
2320 nw 66th ct
gainesville, FL 32653
3523771140
MDR Report Key20048407
Report Number1038671-2024-03038
Device Sequence Number20822060
Product Code JWH
UDI-Device Identifier10885862314277
UDI-Public10885862314277
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
K160484
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 08/13/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/12/2024
Device Catalogue Number200-07-29
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/31/2024
Supplement Date Received by Manufacturer07/22/2024
08/12/2025
Initial Report FDA Received Date08/23/2024
Supplement Report FDA Received Date04/01/2025
08/13/2025
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured05/16/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age59 YR
Patient SexFemale
Patient Weight76 KG
-
-